MedTrace Logo

Opioid Free Anesthesia in Bariatric Surgery

NCT03507634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-09-29

No results posted yet for this study

Summary

This study compares the intraoperative opioid free anesthesia approach in laparoscopic bariatric surgery to a conventional opioid- based anesthesia. Half of participants will receive opioid free anesthesia with dexmedetomidine, lidocaine and ketamine while the other half will receive opioid based anesthesia with fentanyl, remi-fentanyl and ketamine

Conditions

  • Opioid Use
  • Postoperative Pain
  • Postoperative Nausea and Vomiting
  • Bariatric Surgery Candidate

Interventions

DRUG

Opioid free Anesthesia dexmedetomidine and lidocaine

Opioid free anesthesia with dexmedetomidine and lidocaine

DRUG

Opioid based anesthesia Fentanyl and Remifentanyl

Opioid based anesthesia with Fentanyl and Remifentanyl

Sponsors & Collaborators

  • Lebanese American University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507634 on ClinicalTrials.gov